An Open Label, Observational, Prospective Registry of Participants With Sickle Cell Disease (SCD) Treated With Oxbryta® (Voxelotor)® (Voxelotor)

First published 30/09/2024

Last updated 07/04/2025

EU PAS number:

EUPAS1000000170

Study

Finalised

Documents

Study protocol

Initial protocol

GBT440-4R2 (C5341019) Registry Protocol (Prospective) GBT template 3 February 2021_FINAL.pdf

English (770.73 KB - PDF)View document

Updated protocol

No Pedigree GBT440-4R2 (C5341019)_Non-Interventional Study Protocol _Final_v1.0_10Oct2023.pdf

First published: 29/07/2024

English (1.6 MB - PDF)View document

Study results

Study report

C5341019 PROSPECT GBT440-4R2 Final NI Clinical Study Report_Redacted.pdf

English (10.16 MB - PDF)View document

Other information

Secondary tabs